09/11/2024 3:07 PM | Dolsten Mikael (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 3:05 PM | Dolsten Mikael (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/11/2024 3:06 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:26 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:26 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:26 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/16/2024 2:29 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024 2:39 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024 2:16 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024 2:23 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024 3:15 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024 3:05 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/22/2024 2:22 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:05 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) White Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 2:17 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) White Mark Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024 9:34 AM | Makker Gotham (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4/A | |
05/20/2024 3:33 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 3:36 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 3:39 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 3:26 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 3:29 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:27 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:41 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:41 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 2:44 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024 3:05 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024 4:26 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:42 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form DEF 14A | |
04/29/2024 3:43 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form DEFA14A | |
04/29/2024 3:45 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024 3:06 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 2:18 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 4:26 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form PRE 14A | |
04/16/2024 4:45 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) SOUTHWELL DAVID P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/12/2024 3:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) SOUTHWELL DAVID P (Reporting) SOUTHWELL DAVID P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024 7:39 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) White Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 2:11 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) White Mark Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024 8:47 AM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/03/2024 5:02 PM | Ondrey Aaron (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 5:07 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Schwartz Jonathan David (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad) Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs…
A predicted Trump would win.
You won’t believe what he’s predicting now. Click here to see it because it’s a SHOCKER… |
03/29/2024 4:17 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/25/2024 7:54 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 7:58 PM | Makker Gotham (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 10:39 AM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:54 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:48 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 2:54 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 1:59 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 3:37 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) White Mark Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 7:54 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Wilson Martin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:28 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Shah Gaurav (Reporting)
| Form 144/A | |
02/16/2024 3:31 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Wilson Martin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:37 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:22 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024 3:26 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024 9:17 AM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
01/23/2024 3:22 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:05 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 2:16 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 10:43 AM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/12/2023 7:51 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Woods Keith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 7:42 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Woods Keith (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/16/2023 6:24 PM | Makker Gotham (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 5:58 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:09 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) Shah Gaurav (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:17 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 2:21 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 2:21 PM | Patel Kinnari (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023 2:28 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) Shah Gaurav (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023 3:40 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/25/2023 8:38 AM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/20/2023 5:37 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4/A | |
10/20/2023 2:19 PM | Militello John (Reporting) ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2023 8:02 PM | Makker Gotham (Reporting) ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2023 3:05 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 3:09 PM | ROCKET PHARMACEUTICALS, INC. (Filer) Rocket Pharmaceuticals (Filer)
| Form 424B5 | |
09/19/2023 3:15 PM | ROCKET PHARMACEUTICALS, INC. (Subject) Rocket Pharmaceuticals (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
09/19/2023 3:15 PM | ROCKET PHARMACEUTICALS, INC. (Issuer) Rocket Pharmaceuticals (Issuer) RTW INVESTMENTS, LP (Reporting) WONG RODERICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |